《瑞信窝轮》吉利倒跌医药股回稳,留意吉利购21053、石药购13837
近期强势的吉利汽车(0175),周二先升後回软,高位曾见13.88元的逾两个月高位,但及後倒跌逾1%。向上阻力留意14元,支持参考13元。看好可留意吉利购21053,行使价14.90元,20年4月到期。相反看淡可留意吉利沽25419,行使价11.08元,20年3月到期。或50兑1吉利熊61458,收回价14.08元,行使价14.58元,20年4月到期。
另一只汽车股长城汽车(2333),八月汽车销量按年增逾9%,股价周二曾升逾4%,一度高见5.6元水平。看好可留意长汽购20590,行使价5.89元,20年4月到期。
早前强势的医药股,近日整固过後,周二略见回稳。石药集团(1093)周二曾升逾1%至15.7元以上。向上阻力留意16元,支持参考15.5元。看好可考虑石药购13837,行使价16.88元,19年12月到期。相反看淡可留意石药沽25458,行使价13.28元,20年3月到期。或石药熊64453,收回价17.88元,行使价18.58元,20年1月到期。
中国生物制药(1177)周二曾重上11元,看好可考虑中药购23888,行使价12.68元,20年2月到期。相反看淡可留意中药沽24621,行使价9.08元,20年3月到期。
港资股未见起色,本周四公布业绩的新地(0016),周二反覆整固,徘徊在115元附近。看好可留意新地购21972,行使价124.88元,20年2月到期。或新地牛52599,收回价102.88元,行使价101.38元,20年4月到期。相反看淡则可留意新地沽23804,行使价109.78元,20年2月到期。或新地熊52188,收回价125.88元,行使价127.38元,20年2月到期。长实集团(1113)周二跌约1%,曾失守55元。看好可留意长实购23479,行使价54.88元,20年2月到期。
(本结构性产品并无抵押品)
《瑞信香港认股证及牛熊证销售主管何启聪》
免责声明:笔者为瑞士信贷(香港)有限公司的代表 ,并身为证监会持牌人,并无持有相关上市公司的任何财务权益。本文内容仅供参考,并不构成要约、建议或促使任何人士提呈买卖或认购任何证券。结构性产品价格可急升或急跌,投资者或会蒙受全盘损失。本产品并无抵押品。如发行人无力偿债或违约,投资者可能无法收回部份或全部应收款项。牛熊证备强制赎回机制而可能被提早终止,届时(i)N类牛熊证投资者将不获发任何金额;而(ii)R类牛熊证之剩余价值可能为零。有关恒生指数或恒生中国企业指数的免责声明,请参阅上市文件。过往表现并不反映将来表现。投资前,投资者应了解风险,并谘询专业顾问及查阅有关上市文件。瑞信之联属公司为结构性产品之流通量提供者,亦可能是唯一报价者。本文任何内容概不构成投资、法律、会计或税务意见、并无声明任何投资或策略适合或符合阁下的个别情况。结构性产品交投量并不是结构性产品表现的指标,投资者不应仅依赖交投量历史高位数据以厘定结构性产品日後的表现。~重要声明:
以上资讯由第三方提供,AASTOCKS.com Limited对於任何包含於、经由、连结、下载或从任何与本网站有关服务所获得之资讯、内容或广告,不声明或保证其内容之正确性或可靠性。对於您透过本网站上之广告、资讯或要约而展示、购买或取得之任何产品、资讯资料,本公司亦不负品质保证之责任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.